产品详情
简单介绍:
GLY-220
Product Pipeline
Glycadia’s proprietary new chemical entities include
GLY-220
Glycadia, Inc. is a clinical-stage biopharmaceutical company developing therapeutics for the prevention and treatment of vascular complications of diabetes.
详情介绍:
GLY-220
Product Pipeline
Glycadia’s proprietary new chemical entities include
GLY-220
Product Pipeline
Glycadia’s proprietary new chemical entities include
GLY-220
Glycadia, Inc. is a clinical-stage biopharmaceutical company developing therapeutics for the prevention and treatment of vascular complications of diabetes.
相关文章